Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused ... Milestone’s New Drug Application (NDA) for CARDAMYST™ (etripamil) nasal spray, its lead investigational product ...

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research Report) and keeping the ...

PDUFA date of March 27, 2025 for CARDAMYST (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT targe ...

Resyca® specialises in the development and manufacturing of compact, user-friendly soft mist inhalation and soft nasal spray devices, incorporating the proprietary Medspray micro-nozzle technology.

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular ... Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused ...

Doctors shared their must-have sick season buys with The Post, revealing which medicines, supplements and tools you should ...

They work by delivering a fine mist of medication into your nostrils ... Knowing how to use a nasal spray is important, as doing it incorrectly could affect the dose you receive.

The South Carolina Department of Public Health announced Friday that the state has suffered its first pediatric flu-related death of the season.